Skip to primary content

PREMIO COLLAB project awarded 8 million € by Horizon Europe

CAI-X is proud to be part of PREMIO COLLAB, a new project starting in January 2024, which aims to prolong overall survival and improve the quality of life of metastatic breast cancer patients.

PREMIO COLLAB has recently been awarded 8 million euros by Horizon Europe, and it is the first Danish project to receive funding as part of the EU Cancer Mission.

The project will be led by Malene Grubbe Hildebrandt and her team at the Department of Nuclear Medicine at OUH in collaboration with a dedicated consortium of Danish and European partners.

CAI-X will assist with project management.

Read more about the project here.